Naoya Tsurushita

Summary

Affiliation: Protein Design Labs
Country: USA

Publications

  1. ncbi request reprint Humanization of a chicken anti-IL-12 monoclonal antibody
    Naoya Tsurushita
    Protein Design Labs, Inc, 34801 Campus Drive, Fremont, CA 94555, USA
    J Immunol Methods 295:9-19. 2004
  2. ncbi request reprint Whole IgG surface display on mammalian cells: Application to isolation of neutralizing chicken monoclonal anti-IL-12 antibodies
    Yoshiko Akamatsu
    PDL BioPharma, Inc, 34801 Campus Drive, Fremont, CA 94555, USA
    J Immunol Methods 327:40-52. 2007
  3. ncbi request reprint Design of humanized antibodies: from anti-Tac to Zenapax
    Naoya Tsurushita
    Protein Design Labs, Inc, 34801 Campus Drive, Fremont, CA 94555, USA
    Methods 36:69-83. 2005
  4. ncbi request reprint An engineered human IgG1 antibody with longer serum half-life
    Paul R Hinton
    Protein Design Labs, Fremont, CA 94555, USA
    J Immunol 176:346-56. 2006
  5. ncbi request reprint Engineered human IgG antibodies with longer serum half-lives in primates
    Paul R Hinton
    Protein Design Labs, Inc, Fremont, California 94555, USA
    J Biol Chem 279:6213-6. 2004
  6. ncbi request reprint Derivation and characterization of cholesterol-independent non-GS NS0 cell lines for production of recombinant antibodies
    Taymar E Hartman
    Process Sciences and Engineering, PDL BioPharma, Inc, 34801 Campus Drive, Fremont, California 94555, USA
    Biotechnol Bioeng 96:294-306. 2007
  7. pmc Characterization of humanized antibodies secreted by Aspergillus niger
    Michael Ward
    Genencor International, Inc, Palo Alto, California 94304, USA
    Appl Environ Microbiol 70:2567-76. 2004
  8. pmc Amphiregulin and epidermal hyperplasia: amphiregulin is required to maintain the psoriatic phenotype of human skin grafts on severe combined immunodeficient mice
    Narasimharao Bhagavathula
    Department of Pathology, University of Michigan, 1301 Catherine Rd, Box 0602, Ann Arbor, MI 48109, USA
    Am J Pathol 166:1009-16. 2005
  9. doi request reprint CS1, a potential new therapeutic antibody target for the treatment of multiple myeloma
    Eric D Hsi
    Clinical Pathology, Cleveland Clinic Foundation, Cleveland, Ohio, USA
    Clin Cancer Res 14:2775-84. 2008

Collaborators

  • Taymar E Hartman
  • Stephen Keller
  • Michael Ward
  • John E Burky
  • Frits van Rhee
  • JAMES J VARANI
  • Mohamad Hussein
  • Daniel E H Afar
  • Paul R Hinton
  • Eric D Hsi
  • Yin Zhang
  • Yoshiko Akamatsu
  • Gao Liu
  • Shankar Kumar
  • Meina Tao Tang
  • Narasimharao Bhagavathula
  • Mary G Johlfs
  • Joanna M Xiong
  • Mahrukh Huseni
  • Marna B Williams
  • Audie G Rice
  • Benny P Shum
  • Amulya Nanisetti
  • Franklin Fuh
  • Susann Szmania
  • Susan Rhodes
  • Roxanne Steinle
  • Myles Dillon
  • Vladimir Vexler
  • Anne van Abbema
  • Bart Barlogie
  • John D Shaughnessy
  • Fenghuang Zhan
  • Balaji Balasa
  • David Powers
  • Aparna Draksharapu
  • Melanie Wong
  • Shihao Chen
  • Kanokwan Pakabunto
  • Zhenghai Xu
  • Lorraine Gemmell
  • Paul Hinton
  • Nicholas F Landolfi
  • Gary J Fisher
  • John J Voorhees
  • Archana B Thakur
  • Kamalakar C Nerusu
  • Zenghai H Xu
  • Max Vasquez
  • Kelly C Ong
  • Kelly Hanestad
  • Chuck Bullock
  • J Yun Tso

Detail Information

Publications9

  1. ncbi request reprint Humanization of a chicken anti-IL-12 monoclonal antibody
    Naoya Tsurushita
    Protein Design Labs, Inc, 34801 Campus Drive, Fremont, CA 94555, USA
    J Immunol Methods 295:9-19. 2004
    ....
  2. ncbi request reprint Whole IgG surface display on mammalian cells: Application to isolation of neutralizing chicken monoclonal anti-IL-12 antibodies
    Yoshiko Akamatsu
    PDL BioPharma, Inc, 34801 Campus Drive, Fremont, CA 94555, USA
    J Immunol Methods 327:40-52. 2007
    ..The mammalian surface display vector developed in this work facilitates the isolation of monoclonal antibodies from essentially any species...
  3. ncbi request reprint Design of humanized antibodies: from anti-Tac to Zenapax
    Naoya Tsurushita
    Protein Design Labs, Inc, 34801 Campus Drive, Fremont, CA 94555, USA
    Methods 36:69-83. 2005
    ....
  4. ncbi request reprint An engineered human IgG1 antibody with longer serum half-life
    Paul R Hinton
    Protein Design Labs, Fremont, CA 94555, USA
    J Immunol 176:346-56. 2006
    ..Ag binding was unaffected by the Fc mutations, while several effector functions appeared to be minimally altered. These properties suggest that engineered Abs with longer serum half-lives may prove to be effective therapeutics in humans...
  5. ncbi request reprint Engineered human IgG antibodies with longer serum half-lives in primates
    Paul R Hinton
    Protein Design Labs, Inc, Fremont, California 94555, USA
    J Biol Chem 279:6213-6. 2004
    ..5. A pharmacokinetics study of two mutant IgG2 antibodies with increased FcRn binding affinity indicated that they had serum half-lives in rhesus monkeys approximately 2-fold longer than the wild-type antibody...
  6. ncbi request reprint Derivation and characterization of cholesterol-independent non-GS NS0 cell lines for production of recombinant antibodies
    Taymar E Hartman
    Process Sciences and Engineering, PDL BioPharma, Inc, 34801 Campus Drive, Fremont, California 94555, USA
    Biotechnol Bioeng 96:294-306. 2007
    ..These characteristics are advantageous for use of this NS0 cell line platform for manufacturing therapeutic antibodies...
  7. pmc Characterization of humanized antibodies secreted by Aspergillus niger
    Michael Ward
    Genencor International, Inc, Palo Alto, California 94304, USA
    Appl Environ Microbiol 70:2567-76. 2004
    ....
  8. pmc Amphiregulin and epidermal hyperplasia: amphiregulin is required to maintain the psoriatic phenotype of human skin grafts on severe combined immunodeficient mice
    Narasimharao Bhagavathula
    Department of Pathology, University of Michigan, 1301 Catherine Rd, Box 0602, Ann Arbor, MI 48109, USA
    Am J Pathol 166:1009-16. 2005
    ..These data also suggest that the hyperplastic response occurring in nonpsoriatic human skin on transplantation to the SCID mouse is mediated, in large part, by amphiregulin...
  9. doi request reprint CS1, a potential new therapeutic antibody target for the treatment of multiple myeloma
    Eric D Hsi
    Clinical Pathology, Cleveland Clinic Foundation, Cleveland, Ohio, USA
    Clin Cancer Res 14:2775-84. 2008
    ....